Diaceutics Presenting at Canaccord Genuity 44th Annual Growth Conference
Belfast and London, 5 August 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry today announces that management will attend and present at the Canaccord Genuity 44th Annual Growth Conference taking place on August 13-15, 2024 in Boston, MA.
The Conference brings together investors from around the world with some of the best and most promising growth companies in Canaccord's core sectors - Technology, Healthcare, Digital & Tech-Enabled Health, Sustainability, Industrials, and Consumer & Retail. For more information please click here.
Enquiries:
|
Diaceutics PLC |
|
|
Ryan Keeling, Chief Executive Officer Nick Roberts, Chief Financial Officer |
Tel: +44 (0)28 9040 6500 |
|
Stifel Nicolaus Europe Limited (Nomad & Broker) |
Tel: +44 (0)20 7710 7600 |
|
Ben Maddison, Nick Harland, Kate Hanshaw |
|
|
Alma Strategic Communications |
Tel: +44(0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon |
diaceutics@almastrategic.com |
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.